Company Search:
Advanced Search
Sponsored Links
ImmuCell Corporation Company Snapshot
ImmuCell Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares ImmuCell with three other companies in this sector in the United States: Immunomedics, Inc. (2015 sales of $5.65 million of which 100% was Biopharma Products), Celldex Therapeutics, Incorporation ($5.48 million of which 100% was Health Care Products), and Navidea Biopharmaceuticals Incorporated ($13.25 million of which 100% was Diagnostics).

Sales Analysis. During the year ended December of 2015, sales at ImmuCell were $10.23 million. This is an increase of 34.6% versus 2014, when the company's sales were $7.60 million. This was the fifth consecutive year of sales increases at ImmuCell (and since 2010, sales have increased a total of 133%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ImmuCell Corporation
  Stock Performance Chart for ImmuCell Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 6.05
(Figures in U.S. Dollars)
1 Week 0.8%   13 Weeks 1.7%  
4 Weeks -22.3%   52 Weeks -22.2%  
ImmuCell Corporation Key Data:
  Ticker: ICCC Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 10,228,689
(Year Ending Jan 2016).
Employees: 29
  Currency: U.S. Dollars Market Cap: 25,334,436
  Fiscal Yr Ends: December Shares Outstanding: 4,187,510
  Share Type: Common Closely Held Shares: 1,433,092
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.